Lanzamiento Enero 2027

Ensayo controlado aleatorizado2006Financiación no declarada

Effects of exercise and creatine on myosin heavy chain isoform composition in patients with Charcot-Marie-Tooth disease

Smith CA, Chetlin RD, Gutmann L, Yeater RA, Alway SE

Muscle & nerve · 23 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2006-07-31 · Muscle Nerve · vol. 34 · número 5 · págs. 586–594
Editorial
Wiley
Citado
32 citas · más que el 77% de estudios similares · 1.2× el promedio de su campo
Referencias
42 trabajos
Acceso
De pago
Áreas de investigación
Muscle Physiology and Disorders · Hereditary Neurological Disorders · Muscle metabolism and nutrition
Palabras clave
Charcot-Marie-Tooth disease, myosin heavy chain isoforms, creatine supplementation, resistance training, vastus lateralis, chair rise time, muscle function
MeSH
muscle, skeletal, humans, charcot-marie-tooth disease, creatine, myosin heavy chains, protein isoforms, exercise test, biopsy, treatment outcome, exercise therapy, double-blind method, exercise tolerance, muscle contraction, physical fitness, dietary supplements, adult, middle aged, quadriceps muscle

5 autores

  • Cheryl A. S. Smith🇺🇸West Virginia University
  • Robert D. Chetlin🇺🇸West Virginia University
  • Laurie Gutmann🇺🇸West Virginia University
  • RACHEL A. YEATER🇺🇸West Virginia University
  • Stephen E. Alway🇺🇸 · autor de correspondenciaWest Virginia University

Resumen

El texto original del estudio, en el idioma en que se publicó.

It is not known whether myosin heavy chain (MHC) content changes in response to exercise training or creatine supplementation in subjects with Charcot-Marie-Tooth disease (CMT). Based on previous data, we hypothesized that resistance exercise and creatine would increase the percentage of type I MHC composition in the vastus lateralis muscle and that myosin isoform changes would correlate with improved chair rise-time in CMT subjects. To test this hypothesis, 18 CMT subjects were randomly assigned to either a placebo or creatine group. All subjects performed a 12-week, home-based, moderate-intensity resistance training program. Chair rise-time was measured before and after the training program. Muscle biopsies were obtained from the vastus lateralis before and after the 12-week program. Gel electrophoresis showed a significant decrease (approximately 30%) in MHC type I in CMT subjects given creatine supplementation when compared with placebo. There was a nonsignificant increase in both MHC type IIa (approximately 23%) and MHC type IIx (approximately 7%) in CMT subjects given creatine. Reduced MHC type I content and increased MHC type IIa content correlated with faster chair rise-times (i.e., improved muscle performance). The training-induced change in MHC IIa content was inversely correlated with chair rise-time in CMT subjects given creatine. When the two subject groups were combined, there was a linear, negative relationship between the change in MHC type IIa content and chair rise-time after training and a positive relationship between the training-induced change in MHC type I content and chair rise-time. These data suggest that improved function (chair rise-time) was associated with a lower level of MHC type I and increased MHC type IIa composition. Furthermore, the data are consistent with the hypothesis that creatine supplementation alters MHC composition in CMT patients undergoing resistance training and that MHC changes associated with creatine supplementation can improve muscle function.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.